Renal Denervation in CKD Hypertensive Patients: Would it be Possible to Prevent the Development of Risk Factors Responsible for Sudden Cardiac Death in this Population?

Marcio Galindo Kiuchi, Miguel Luis Graciano, Maria Angela Magalhães de Queiroz Carreira, Tetsuaki Kiuchi, Jocemir Ronaldo Lugon


no abstract for letters

Full Text:



Cerasola G, Nardi E, Mulè G, Palermo A, Cusimano P, Guarneri M, Arsena R, Giammarresi G, Carola Foraci A, Cottone S: Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function. Nephrology (Carlton). 2010; 15: 203–210.

Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125–134.

Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G: Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis. 2005; 46: 320–327.

Moran A, Katz R, Jenny NS, Astor B, Bluemke DA, Lima JA, Siscovick D, Bertoni AG, Shlipak MG: Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: The multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis. 2008; 52:839–848.

Mark PB, JohnstonN,Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG: Redefinition of uremic cardiomyopathy by contrast-enhanced cardiacmagnetic resonance imaging. Kidney Int. 2006; 69:1839–1845.

Cioffi G, Tarantini L, Frizzi R, Stefenelli C, Russo TE, Selmi A, Toller C, Furlanello F, de Simone G: Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens. 2011; 29:565–573.

Schroeder AP, Kristensen BO, Nielsen CB, Pedersen EB: Heart function in patients with chronic glomerulonephritis and mildly to moderately impaired renal function. An echocardiographic study. Blood Press. 1997; 6: 286–293.

Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999; 341:1276–1283.

Amann K, Kronenberg G, Gehlen F, Wessels S, Orth S, Münter K, Ehmke H, Mall G, Ritz E. Cardiac remodelling in experimental renal failure—an immunohistochemical study. NephrolDial Transplant. 1998; 13: 1958–1966.

Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant. 1990; 5: 39–44.

Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998; 32:1454–1459.

Reinier K, Dervan C, Singh T, Uy-Evanado A, Lai S, Gunson K, Jui J, Chugh SS. Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Heart Rhythm. 2011; 8: 1177–1182.

Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY. Characterization of the peri-infarct zone by contrast enhanced cardiac magnetic resonance imaging is a powerful predictor of postmyocardial infarction mortality. Circulation. 2006; 114: 32–39.

Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet. 2007; 369:1208–1219.

Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverterdefibrillator. Circ Cardiovasc Imaging . 2009; 2: 183–190.

Koprowski A, Gruchala M, Rynkiewicz A. Management of left ventricular diastolic heart failure: is it only blood pressure control? Curr Opin Cardiol 2009;24:161-166.

Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259.

Kiuchi MG, Chen S, Graciano ML, de Queiroz Carreira MA, Kiuchi T, Andrea BR, Lugon JR. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease. Int J Cardiol. 2015 Apr 7;190:29-31. doi: 10.1016/j.ijcard.2015.04.039. [Epub ahead of print] No abstract available

Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group. J Am Soc Echocardiogr 2005;18:1440–63.

Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57:450–8.

Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987; 317:1098.

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4



  • There are currently no refbacks.

Copyright (c) 2016 Marcio Galindo Kiuchi, Miguel Luis Graciano, Maria Angela Magalhães de Queiroz Carreira, Tetsuaki Kiuchi, Jocemir Ronaldo Lugon

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2518-6140 (on-line version)